Vincent Bouldoires

Vincent Bouldoires is a strategic executive in the pharmaceutical and biotechnology industry, with over 25 years of experience in managing and developing commercial entities including in rare diseases and orphan drugs. His expertise spans market access, regulatory affairs, and the implementation of high-impact commercial strategies, including negotiations with health authorities.

In 2024, Vincent founded Orphan Access Consulting and joined Orphan Now, providing support to biotechnology companies in their market access strategies, leveraging his in-depth knowledge of the clinical, regulatory and economic challenges specific to rare diseases.

Prior to founding Orphan Access Consulting, Vincent served 7 years as General Manager & Responsible Pharmacist at Amryt / Aegerion France & Benelux, where he led the successful launch of two orphan drugs in France and the Netherlands. He also managed early access programs in close collaboration with health authorities and key opinion leaders in the field.

Vincent has also held leadership positions at Thermo Fisher Scientific, Mylan, and Teva, where he demonstrated his ability to structure and develop organizations of various sizes, delivering tangible results in growth, operational optimization, and market share expansion. His transparent and authentic leadership style fosters a climate of trust and respect, empowering teams to excel and surpass their objectives.

With a master’s degree in marketing and management from Bordeaux Business School and a pharmacy degree from Toulouse University, Vincent combines a strong scientific background with proven strategic and operational expertise. He is also certified responsible pharmacist providing him with a comprehensive understanding of the regulatory and pharmacovigilance challenges related to drug commercialization in France.

Passionate about healthcare innovation and making therapeutic solutions available to patients, Vincent continues to leverage his expertise to support companies aiming to establish and succeed in the French market.